You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Company Profile

Johnson & Johnson Inc in Consumer Health

Aug 2012

Price: US$525

About this Report

About this Report


Euromonitor International's report on Johnson & Johnson Inc delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy.

Company and market share data provide a detailed look at the financial position of Johnson & Johnson Inc, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Johnson & Johnson Inc This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWOT analysis of Johnson & Johnson Inc provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research You Can Trust

Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out.

Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Delivery:
Reports are delivered in pdf format and can be downloaded from your online account (called My Pages) immediately after purchase.

Table of Contents

Table of Contents

Scope of the Report

Scope

Strategic Evaluation

Key company facts

Consumer products recovers

SWOT: Johnson & Johnson Inc

Strategic objectives and challenges

Competitive Positioning

Sales recover but still underperform

Most major players deliver strong performance

Market Assessment

Product recalls hit core product categories

Global presence benefits overall operation

Category and Geographic O pportunities

J&J remains the leader in global OTC despite share erosion

Category and Geographic Opportunities

Things got worse in the core US market

Value sales declined dramatically

Key categories and brands undermined

Private label and key competitors continue to take advantage

Strong challenges ahead

Acquisition boosts performance in Eastern Europe

Russia holds extensive prospects

Sustained growth in Asia Pacific

Key categories drive value growth in China

Intense competition between domestic and global players

Underperforms in Latin America

NRT smoking cessation aids partly offset underperformance

UK drives performance in Western Europe

A pleasant surprise in Spain

Global strength in NRT smoking cessation aids

Opportunity for NRT lies in both mature and emerging markets

Uncontested leader in wound care

US and China offer good growth potential

Brand Strategy

Brand equity jeopardised by continuous recalls

Tylenol: Continued product recalls hit sales

Recovering sales a considerable challenge ahead

Daktarin : Benefits from no exposure to the troubled US market

Daktarin : Stepping up presence in untapped areas for growth

Operations

Mounting challenge in consumer health operations

J&J family of companies for consumer business (1)

J&J family of companies for consumer business (2)

J&J family of companies for consumer business (3)

Recommendations

Need to restore trust and target emerging market growth

Samples

Please update/install flash.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!